The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Imigran     1-[3-(2-dimethylaminoethyl)- 1H-indol-5-yl]...

Synonyms: Sumatran, Imitrex, Zecuity, Alsuma, Sumax, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Imigran


Psychiatry related information on Imigran


High impact information on Imigran


Chemical compound and disease context of Imigran


Biological context of Imigran


Anatomical context of Imigran


Associations of Imigran with other chemical compounds


Gene context of Imigran


Analytical, diagnostic and therapeutic context of Imigran


  1. Brain stem activation in spontaneous human migraine attacks. Weiller, C., May, A., Limmroth, V., Jüptner, M., Kaube, H., Schayck, R.V., Coenen, H.H., Diener, H.C. Nat. Med. (1995) [Pubmed]
  2. Sumatriptan-induced chest pain. Hood, S., Birnie, D., MacIntyre, P.D., Hillis, W.S. Lancet (1994) [Pubmed]
  3. Transmural myocardial infarction with sumatriptan. Ottervanger, J.P., Paalman, H.J., Boxma, G.L., Stricker, B.H. Lancet (1993) [Pubmed]
  4. Sumatriptan and ischaemic heart disease. Chester, A.H., O'Neil, G.S., Yacoub, M.H. Lancet (1993) [Pubmed]
  5. Sumatriptan-induced stroke in sagittal sinus thrombosis. Cavazos, J.E., Caress, J.B., Chilukuri, V.R., Devlin, T., Gray, L., Hurwitz, B.J. Lancet (1994) [Pubmed]
  6. A subfamily of 5-HT1D receptor genes. Hartig, P.R., Branchek, T.A., Weinshank, R.L. Trends Pharmacol. Sci. (1992) [Pubmed]
  7. Growth hormone response to sumatriptan (5-HT1D agonist) challenge in seasonal affective disorder: effects of light therapy. Yatham, L.N., Lam, R.W., Zis, A.P. Biol. Psychiatry (1997) [Pubmed]
  8. Serotonergic functioning in children with oppositional defiant disorder: a sumatriptan challenge study. Snoek, H., van Goozen, S.H., Matthys, W., Sigling, H.O., Koppeschaar, H.P., Westenberg, H.G., van Engeland, H. Biol. Psychiatry (2002) [Pubmed]
  9. The relationship between repetitive behaviors and growth hormone response to sumatriptan challenge in adult autistic disorder. Hollander, E., Novotny, S., Allen, A., Aronowitz, B., Cartwright, C., DeCaria, C. Neuropsychopharmacology (2000) [Pubmed]
  10. Treatment of acute migraine with subcutaneous sumatriptan. Cady, R.K., Wendt, J.K., Kirchner, J.R., Sargent, J.D., Rothrock, J.F., Skaggs, H. JAMA (1991) [Pubmed]
  11. Clinical and pathophysiological characteristics of acute-onset functional dyspepsia. Tack, J., Demedts, I., Dehondt, G., Caenepeel, P., Fischler, B., Zandecki, M., Janssens, J. Gastroenterology (2002) [Pubmed]
  12. The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine. Tfelt-Hansen, P., Henry, P., Mulder, L.J., Scheldewaert, R.G., Schoenen, J., Chazot, G. Lancet (1995) [Pubmed]
  13. Is chest pain after sumatriptan oesophageal in origin? Houghton, L.A., Foster, J.M., Whorwell, P.J., Morris, J., Fowler, P. Lancet (1994) [Pubmed]
  14. Potentiation of alpha-adrenoceptor-mediated vasoconstriction by sumatriptan. Buikema, H., Grandjean, J.G. Lancet (1993) [Pubmed]
  15. Neurogenic inflammation in the pathophysiology and treatment of migraine. Moskowitz, M.A. Neurology (1993) [Pubmed]
  16. Eletriptan vs sumatriptan: a double-blind, placebo-controlled, multiple migraine attack study. Sandrini, G., Färkkilä, M., Burgess, G., Forster, E., Haughie, S. Neurology (2002) [Pubmed]
  17. Buspirone, but not sumatriptan, induces miosis in humans: relevance for a serotoninergic pupil control. Fanciullacci, M., Sicuteri, R., Alessandri, M., Geppetti, P. Clin. Pharmacol. Ther. (1995) [Pubmed]
  18. Clozapine treatment of persistent paroxysmal dyskinesia associated with concomitant paroxetine and sumatriptan use. Abraham, J.T., Brown, R., Meltzer, H.Y. Biol. Psychiatry (1997) [Pubmed]
  19. Zolmitriptan: a review of its use in migraine. Spencer, C.M., Gunasekara, N.S., Hills, C. Drugs (1999) [Pubmed]
  20. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Moskowitz, M.A. Trends Pharmacol. Sci. (1992) [Pubmed]
  21. Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation. MacIntyre, P.D., Bhargava, B., Hogg, K.J., Gemmill, J.D., Hillis, W.S. Circulation (1993) [Pubmed]
  22. Persistence of attacks of cluster headache after trigeminal nerve root section. Matharu, M.S., Goadsby, P.J. Brain (2002) [Pubmed]
  23. Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Goadsby, P.J., Edvinsson, L. Brain (1994) [Pubmed]
  24. Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan. Friberg, L., Olesen, J., Iversen, H.K., Sperling, B. Lancet (1991) [Pubmed]
  25. Endocrine effects of sumatriptan. Rolandi, E., Franceschini, R., Cataldi, A., Barreca, T. Lancet (1992) [Pubmed]
  26. 5-HT(1)-like receptor agonists and the pathophysiology of migraine. Saxena, P.R., Ferrari, M.D. Trends Pharmacol. Sci. (1989) [Pubmed]
  27. Variable participation of 5-HT1-like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated coronary arteries. 5-HT1-like receptors resemble cloned 5-HT1D beta receptors. Kaumann, A.J., Frenken, M., Posival, H., Brown, A.M. Circulation (1994) [Pubmed]
  28. Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT 1B/1D receptor agonists. Levy, D., Jakubowski, M., Burstein, R. Proc. Natl. Acad. Sci. U.S.A. (2004) [Pubmed]
  29. Two members of a distinct subfamily of 5-hydroxytryptamine receptors differentially expressed in rat brain. Erlander, M.G., Lovenberg, T.W., Baron, B.M., de Lecea, L., Danielson, P.E., Racke, M., Slone, A.L., Siegel, B.W., Foye, P.E., Cannon, K. Proc. Natl. Acad. Sci. U.S.A. (1993) [Pubmed]
  30. SUMATRIPTAN: a receptor-targeted treatment for migraine. Moskowitz, M.A., Cutrer, F.M. Annu. Rev. Med. (1993) [Pubmed]
  31. Microiontophoretic application of serotonin (5HT)1B/1D agonists inhibits trigeminal cell firing in the cat. Storer, R.J., Goadsby, P.J. Brain (1997) [Pubmed]
  32. Sumatriptan can inhibit trigeminal afferents by an exclusively neural mechanism. Hoskin, K.L., Kaube, H., Goadsby, P.J. Brain (1996) [Pubmed]
  33. Actions of the 5-hydroxytryptamine 1 receptor agonist sumatriptan on interdigestive gastrointestinal motility in man. Tack, J., Coulie, B., Wilmer, A., Peeters, T., Janssens, J. Gut (1998) [Pubmed]
  34. 5-Hydroxytryptamine facilitates cholinergic bronchoconstriction in human and guinea pig airways. Takahashi, T., Ward, J.K., Tadjkarimi, S., Yacoub, M.H., Barnes, P.J., Belvisi, M.G. Am. J. Respir. Crit. Care Med. (1995) [Pubmed]
  35. Role of the serotonin receptor subtype 5-HT1D on basal and stimulated growth hormone secretion. Mota, A., Bento, A., Peñalva, A., Pombo, M., Dieguez, C. J. Clin. Endocrinol. Metab. (1995) [Pubmed]
  36. Functional characterization and m-RNA expression of 5-HT receptors mediating contraction in human umbilical artery. Lovren, F., Li, X.F., Lytton, J., Triggle, C. Br. J. Pharmacol. (1999) [Pubmed]
  37. Intravital microscopy on a closed cranial window in mice: a model to study trigeminovascular mechanisms involved in migraine. Gupta, S., Akerman, S., van den Maagdenberg, A., Saxena, P., Goadsby, P., van den Brink, A. Cephalalgia : an international journal of headache. (2006) [Pubmed]
  38. Augmented contraction of the human isolated coronary artery by sumatriptan: a possible role for endogenous thromboxane. Maassen VanDenBrink, A., Bax, W.A., Ferrari, M.D., Zijlstra, F.J., Bos, E., Saxena, P.R. Br. J. Pharmacol. (1996) [Pubmed]
  39. Coronary angiography in migraine patient after subcutaneous sumatriptan. Evers, S., Husstedt, I.W., Enbergs, A. Lancet (1995) [Pubmed]
  40. Coronary side-effect potential of current and prospective antimigraine drugs. MaassenVanDenBrink, A., Reekers, M., Bax, W.A., Ferrari, M.D., Saxena, P.R. Circulation (1998) [Pubmed]
  41. Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms. Moskowitz, M.A., Nozaki, K., Kraig, R.P. J. Neurosci. (1993) [Pubmed]
WikiGenes - Universities